Global Transplant Diagnostics Market Set to Reach a Value of USD 8.5 Billion by 2034

Posted on 2024-08-05 by Future Market Insights in Healthcare // 0 Comments

The global transplant diagnostics market is on track to achieve a remarkable valuation of USD 4.5 billion by 2024, according to recent forecasts. This surge is attributed to regulatory initiatives aimed at standardization and control within the sector, which are paving the way for unprecedented growth opportunities. Projected to experience a Compound Annual Growth Rate (CAGR) of 6.5% between 2024 and 2034, the market is anticipated to soar to approximately USD 8.5 billion by 2034, indicating a promising trajectory for investors and stakeholders alike.

One of the key drivers fueling this expansion is the escalating emphasis on non-invasive diagnostics, which is revolutionizing the landscape of transplant diagnostics. As the demand for safer and more efficient diagnostic techniques continues to rise, the market is witnessing a burgeoning trend towards non-invasive or minimally invasive approaches.

Get Ahead of the Competition: Our Sample Report for Key Insights Transplant Diagnostics Market

Blood-based biomarker assays and imaging technologies are among the forefront of this trend, offering innovative solutions that diminish the necessity for invasive procedures. These advancements not only enhance patient experience but also contribute to the overall efficiency and effectiveness of transplant diagnostics.

With such promising growth prospects on the horizon, the global transplant diagnostics market is poised to unlock new avenues for innovation and development. As regulatory initiatives and technological advancements continue to shape the industry, stakeholders are encouraged to seize the opportunities presented by this dynamic market landscape.

Key Takeaways from the Market Study:

The global transplant diagnostics market was valued at USD 4.2 billion in 2023.
From 2019 to 2023, the market demand expanded at a CAGR of 8.1%.
The market in South Korea is expected to expand at a CAGR of 8.0% through 2034.
By product and service, the instruments segment to account for a CAGR of 6.3% through 2034.
By screening type, pre-transplant diagnostics to be prominent, expanding at a CAGR of 6.1% until 2034.
Transplant diagnostics scope in the United States is significant, expected to rise at a 6.8% CAGR through 2034.

“Advances in organ preservation technologies, such as ex vivo perfusion systems, provide traction to the transplant diagnostics market. Improved preservation methods can extend the viability of organs and provide more time for comprehensive diagnostic assessments,” remarks an FMI analyst.

Competitive Landscape:

Prominent players in the transplant diagnostics market are Becton Dickinson and Company, Bio-Rad Laboratories Inc., Illumina Inc., Immucor Transplant Diagnostics Inc., Thermo Fisher Scientific Inc., CareDx, Affymetrix Inc., Linkage Biosciences, Abbott Laboratories Inc., BioMérieux S.A., and QIAGEN NV, among others.

Recent Development:

In 2022, Biocartis and Ophiomics forged a collaboration aimed at advancing the commercialization of HepatoPredict. The prognostic gene expression signature test is designed to discern patients who will experience benefits from liver transplantation.

Get Instant Access to the Complete Report – Transform Your Strategy

Segmentation Analysis of the Transplant Diagnostics Market:

By Product and Service:

Instruments
Reagents and Consumables

By Screening Type:

Pre Transplant
Post-Transplant

By Organ Type:

Kidney
Liver
Heart
Lung
Pancreas

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick